Your browser doesn't support javascript.
loading
Insulin pen use and diabetes treatment goals: A study from Iran STEPS 2016 survey.
Ebrahimi, Hedyeh; Pishgar, Farhad; Yoosefi, Moein; Moradi, Sedighe; Rezaei, Nazila; Djalalinia, Shirin; Modirian, Mitra; Peykari, Niloofar; Naderimagham, Shohreh; Haghshenas, Rosa; Rahimi, Saral; Jamshidi, Hamidreza; Esteghamati, Alireza; Larijani, Bagher; Farzadfar, Farshad.
Afiliação
  • Ebrahimi H; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Pishgar F; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Yoosefi M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Moradi S; Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Rezaei N; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
  • Djalalinia S; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Modirian M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Peykari N; Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran.
  • Naderimagham S; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Haghshenas R; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Rahimi S; Ministry of Health and Medical Education, Tehran, Iran.
  • Jamshidi H; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Esteghamati A; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Larijani B; Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.
  • Farzadfar F; School of Medicine, Department of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
PLoS One ; 14(8): e0221462, 2019.
Article em En | MEDLINE | ID: mdl-31461470
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Infusão de Insulina / Diabetes Mellitus Tipo 2 / Objetivos / Insulina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Infusão de Insulina / Diabetes Mellitus Tipo 2 / Objetivos / Insulina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã País de publicação: Estados Unidos